| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| SG3199
| LONCASTUXIMAB TESIRINE-LPYL | ANTINEOPLASTIC | INJECTION | VD 7.11 LITER | DNA | B-lymphocyte antigen CD19 UNIPROT P15391 CD19 more at DrugCentral | EMA | |||
